“`html
The Vanguard Small-Cap ETF (Symbol: VB) has an implied analyst target price of $289.65 per unit, indicating a potential upside of 13.63% from its recent trading price of $254.91. This analysis is based on the weighted average of the underlying holdings’ target prices.
Among the ETF’s notable holdings, Amicus Therapeutics Inc (FOLD) has a recent price of $8.24 with an average analyst target of $15.92, representing a 93.16% upside. Beam Therapeutics Inc (BEAM) is priced at $22.97, with a target of $43.80 (90.68% upside), while McGraw Hill Inc (MH) trades at $13.75, targeting $20.97 (52.48% upside).
| Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
|---|---|---|---|---|
| Vanguard Small-Cap ETF | VB | $254.91 | $289.65 | 13.63% |
| Amicus Therapeutics Inc | FOLD | $8.24 | $15.92 | 93.16% |
| Beam Therapeutics Inc | BEAM | $22.97 | $43.80 | 90.68% |
| McGraw Hill Inc | MH | $13.75 | $20.97 | 52.48% |
“`
